Abstract The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to
reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare …

Warfarin has existed for> 7 decades and has been the anticoagulant of choice for many
thromboembolic disorders. The recent introduction of direct‐acting oral anticoagulants …

Patients in sub‐Saharan Africa generally have poor anticoagulation control. We review the
potential reasons for this poor control, as well as the potential solutions. Challenges include …

Background Understanding trends in atrial fibrillation (AF) and atrial flutter (AFL) is crucial for
effective prevention. This study quantifies the burden and identifies key risk factors for …

Cardiovascular diseases are a well‐established cause of death in high‐income countries. In
the last 20 years, Sub‐Saharan Africa (SSA) has seen one of the sharpest increases in …

Abstract Background Atrial Fibrillation (AF) is a major public health problem and one of the
commonest supraventricular arrhythmias. At least 20% of all strokes are directly attributable …

Objectives This study aimed to estimate the budget impact of adopting direct oral
anticoagulants (DOACs) for stroke prevention in patients with nonvalvular atrial fibrillation in …

Abstract Sub-Saharan Africa (SSA) countries are facing an epidemiological shift from
infectious diseases to chronic diseases, such as cardiovascular diseases (CVDs). The …

Background: Atrial fibrillation (AF) is the most common type of arrhythmia encountered in
clinical practice, for which patients are hospitalized. So far, there were few studies …

Background: Sub-Saharan Africa (SSA) countries are facing an epidemiological shift from
infectious diseases to chronic diseases, such as cardiovascular diseases (CVDs). The …